Avalo Therapeutics, Inc. (AVTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Avalo Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.11x | -1.72x | -0.08x | -1.14x | -2.10x | -3.05x |
| P/B Ratio | 2.93x | 0.45x | 0.35x | -4.34x | 7.68x | 7.90x |
| P/S Ratio | 4125.96x | 136.95x | 1.31x | 2.63x | 32.83x | 28.95x |
| Profitability | ||||||
| Gross Margin | 100.0% | 183.0% | 33.3% | 81.0% | 72.4% | 95.5% |
| Operating Margin | -123601.7% | -15535.6% | -1421.6% | -207.4% | -1521.6% | 0.0% |
| Net Margin | -132642.4% | -7965.8% | -1639.5% | -230.8% | -1563.1% | -947.9% |
| EBITDA Margin | -123018.6% | -15497.3% | -1210.3% | -206.5% | -1490.9% | -678.5% |
| Liquidity | ||||||
| Current Ratio | 8.14x | 19.96x | 1.82x | 0.74x | 3.11x | 1.71x |
| Quick Ratio | 8.14x | 19.96x | 1.82x | 0.74x | 3.11x | 1.71x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.00x | 0.07x | -1.83x | 1.44x | 0.02x |
YoY = year-over-year change. Source: FMP..